Biosimilar Insulin and Costs: What Can We Expect?

Journal of Diabetes Science and Technology
Lutz Heinemann

Abstract

The costs for insulin treatment are high, and the steady increase in the number of patients with diabetes on insulin presents a true challenge to health care systems. Therefore, all measures to lower these costs are welcomed by patients, physicians, and health care providers. The market introduction of biosimilar insulins presents an option to lower treatment costs as biosimilars are usually offered at a lower price than the originator product. However, the assumption that a drastic reduction in insulin prices will take place, as was observed with many generic drugs, is most probably not realistic. As the first biosimilar insulin has now been approved in the EU, this commentary discusses a number of aspects that are relevant when it comes to the potential cost reduction we will see with the use of biosimilar insulins.

References

Jul 5, 2011·Journal of Diabetes Science and Technology·Lutz Heinemann, Marcus Hompesch
Aug 28, 2012·Journal of Diabetes Science and Technology·Lutz Heinemann, Douglas B Muchmore
Nov 26, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·María-Isabel Farfan-PortetFrank Hulstaert
May 31, 2014·Journal of Diabetes Science and Technology·Lutz Heinemann, Marcus Hompesch
May 31, 2014·Journal of Diabetes Science and Technology·Alasdair R WilkinsKelly L Close
Mar 19, 2015·The New England Journal of Medicine·Jeremy A Greene, Kevin R Riggs
Mar 20, 2015·Diabetes Technology & Therapeutics·Lutz HeinemannPhilip Home

❮ Previous
Next ❯

Citations

Feb 14, 2017·Diabetes Technology & Therapeutics·Thomas DanneJan Bolinder
Jan 25, 2017·Diabetes Technology & Therapeutics·Luigi F Meneghini, Jacqueline Nicole McNulty
Dec 21, 2017·Postgraduate Medicine·Sarah L AndersonRobert J Tanenberg
Aug 21, 2018·The Annals of Pharmacotherapy·Jack T Rasmussen, Heather J Ipema
Dec 4, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Binita DuttaSteven Simoens
Nov 3, 2016·Journal of Diabetes Science and Technology·Alan W Carter, Lutz Heinemann
Sep 9, 2017·Diabetes Technology & Therapeutics·Lutz Heinemann, Alan W Carter
Feb 26, 2021·TheScientificWorldJournal·José F Santos-NetoBruna A S Machado

❮ Previous
Next ❯

Software Mentioned

BioIns

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Pharmaceutical and Biomedical Analysis
Zsuzsanna Kálmán-SzekeresKatalin Ganzler
Healthcare Financial Management : Journal of the Healthcare Financial Management Association
P M Long
Inquiry : a Journal of Medical Care Organization, Provision and Financing
D R Cohodes
© 2021 Meta ULC. All rights reserved